The diagnostic value of cell block as an adjunct to liquid-based cytology of bronchial washing specimens in the diagnosis and subclassification of pulmonary neoplasms

Cancer Cytopathology

Volumn 120, Issue 2, 2012, Pages 134-141

  Collins, George R ^a   Thomas, Jaiyeola ^a   Joshi, Neelam ^a   Zhang, Songlin ^a  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

Bronchial washing; Cell block; Diagnosis; Liquid based preparations; Lung neoplasms; ThinPrep

Indexed keywords

ARTICLE; CELL BLOCK; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMEAR; TRACHEOBRONCHIAL TOILET; ADENOCARCINOMA; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTODIAGNOSIS; FOLLOW UP; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUMOR; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; BRONCHOALVEOLAR LAVAGE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CYTODIAGNOSIS; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA;

EID: 84861717534     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20181     Document Type: Article

References (21)

1. van der Drift MA, van der Wilt GJ, Thunnissen FB, Janssen JP. A prospective study of the timing and cost-effectiveness of bronchial washing during bronchoscopy for pulmonary malignant tumors. Chest. 2005;128:394-400.
2. Lam WK, So SY, Hsu C, Yu DY. Fiberoptic bronchoscopy in the diagnosis of bronchial cancer: comparison of washings, brushings, and biopsies in central and peripheral tumours. Clin Oncol. 1983;9:35-42.
3. Mak VH, Johnston ID, Hetzel MR, Grubb C. Value of washings and brushings at fibreoptic bronchoscopy in the diagnosis of lung cancer. Thorax. 1990;45:373-376.
4. Jay SJ, Wehr K, Nicholson DP, Smith AL. Diagnostic sensitivity and specificity of pulmonary cytology: comparison of techniques used in conjunction with flexible fiberoptic bronchoscopy. Acta Cytol. 1980;24:304-312.
5. Calabretto ML, Giol L, Sulfaro S. Diagnostic utility of cellblock from bronchial washing in pulmonary neoplasms. Diagn Cytopathol. 1996;15:191-192.
6. Bocking A, Biesterfeld S, Chatelain R, Gien-Gerlach G, Esser E. Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum. Sensitivity and specificity of an alternative to routine cytology. Acta Cytol. 1992;36:37-47.
7. Ng ABP, Horak GC. Factors significant in the diagnostic accuracy of lung cytology in bronchial washing and sputum samples. I. Bronchial washings. Acta Cytol. 1983;27:391-396.
8. Pilotti S, Rilke F, Gribaudi G, Damascelli B, Ravasi G. Transthoracic fine needle aspiration biopsy in pulmonary lesions. Updated results. Acta Cytol. 1984;28:225-232.
9. Michel RP, Lushpihan A, Ahmed MN. Pathologic findings of transthoracic needle aspiration in the diagnosis of localized pulmonary lesions. Cancer. 1983;51:1663-1672.
10. Flint A. Detection of pulmonary neoplasms by bronchial washings. Are cell blocks a diagnostic aid? Acta Cytol. 1993;37:21-23.
11. Hoda RS. Non-gynecologic cytology on liquid-based preparations: a morphologic review of facts and artifacts. Diagn Cytopathol. 2007;35:621-634.
12. Lyubsky S, Thorn R. Application of immunoperoxidase staining to the cell blocks from sputa and bronchial washings. Arch Pathol Lab Med. 1989;113:94-95.
13. Wu M, Szporn AH, Zhang D, et al. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Diagn Cytopathol. 2005;33:223-227.
14. da Cunha Santos G, Liu N, Tsao MS, Kamel-Reid S, Chin K, Geddie WR. Detection of EGFR and KRAS mutations in fine-needle aspirates stored on Whatman FTA cards: is this the tool for biobanking cytological samples in the molecular era? Cancer Cytopathol. 2010; 118:450-456.
15. Sokolova IA, Bubendorf L, O'Hare A, et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer. 2002;96:306-315.
16. Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett Jr. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest. 2006;130:694-701.
17. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361:947-957.
18. Takano T, Ohe Y, Sakamoto H, et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent nonsmall-cell lung cancer. J Clin Oncol. 2005;23:6829-6837.
19. Riely GJ, Politi KA, Miller VA, Pao W. Update on epidermal growth factor receptor mutations in non-small cell lung cancer. Clin Cancer Res. 2006;12:7232-7241.
20. Cohen MB, Weydert JA. Neoplastic pulmonary cytology: why all the fuss over ''NSCLC''? Cancer Cytopathol. 2011; 119:3-4.
21. Karahalli E, Yilmaz A, Turker H, Ozvaran K. Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely? Respiration. 2001;68: 611-614.